AVIRAGEN THERAPEUTICS INC's ticker is AVIR and the CUSIP is 053761102. A total of 32 filers reported holding AVIRAGEN THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $36,000 | -16.3% | 63,075 | 0.0% | 0.00% | – |
| Q3 2017 | $43,000 | +2.4% | 63,075 | 0.0% | 0.00% | – |
| Q2 2017 | $42,000 | +2.4% | 63,075 | 0.0% | 0.00% | – |
| Q1 2017 | $41,000 | -47.4% | 63,075 | 0.0% | 0.00% | – |
| Q4 2016 | $78,000 | -35.5% | 63,075 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $121,000 | +37.5% | 63,075 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $88,000 | – | 63,075 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 2,836,326 | $1,899,000 | 0.58% |
| ARMISTICE CAPITAL, LLC | 1,122,829 | $752,000 | 0.10% |
| TOWERVIEW LLC | 175,000 | $117,000 | 0.06% |
| Carlson Capital Management | 156,485 | $105,000 | 0.03% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 224,477 | $150,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 49,186 | $33,000 | 0.00% |
| Virtu KCG Holdings LLC | 222,934 | $149,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 204,470 | $137,000 | 0.00% |
| Renaissance Technologies | 1,058,103 | $708,000 | 0.00% |
| WEDBUSH SECURITIES INC | 14,131 | $9,000 | 0.00% |